Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 26.9
(-0.37%)
HKD 26.9
(-0.37%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 25.04 Billion CNY | 0.72% |
| 2022 | 24.86 Billion CNY | 11.14% |
| 2021 | 22.37 Billion CNY | 8.65% |
| 2020 | 20.59 Billion CNY | 14.54% |
| 2019 | 17.97 Billion CNY | 3.09% |
| 2018 | 17.43 Billion CNY | 9.68% |
| 2017 | 15.89 Billion CNY | 50.99% |
| 2016 | 10.52 Billion CNY | 30.35% |
| 2015 | 8.07 Billion CNY | 10.61% |
| 2014 | 7.3 Billion CNY | 11.22% |
| 2013 | 6.56 Billion CNY | 16.55% |
| 2012 | 5.63 Billion CNY | 22.4% |
| 2011 | 4.6 Billion CNY | 25.69% |
| 2010 | 3.66 Billion CNY | 17.21% |
| 2009 | 3.12 Billion CNY | 6.86% |
| 2008 | 2.92 Billion CNY | -0.74% |
| 2007 | 2.94 Billion CNY | 19.82% |
| 2006 | 2.45 Billion CNY | 13.62% |
| 2005 | 2.16 Billion CNY | -1.74% |
| 2004 | 2.2 Billion CNY | 3.41% |
| 2003 | 2.12 Billion CNY | 14.7% |
| 2002 | 1.85 Billion CNY | 10.75% |
| 2001 | 1.67 Billion CNY | 5.53% |
| 2000 | 1.58 Billion CNY | 1.95% |
| 1999 | 1.55 Billion CNY | -0.2% |
| 1998 | 1.56 Billion CNY | 3.36% |
| 1997 | 1.51 Billion CNY | 14.69% |
| 1996 | 1.31 Billion CNY | 18.64% |
| 1995 | 1.1 Billion CNY | 27.55% |
| 1994 | 870.12 Million CNY | 9.14% |
| 1993 | 797.27 Million CNY | 34.16% |
| 1992 | 594.26 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 25.18 Billion CNY | 0.58% |
| 2024 Q3 | 24.9 Billion CNY | -2.61% |
| 2024 Q2 | 25.57 Billion CNY | 1.53% |
| 2023 Q2 | 25.72 Billion CNY | 0.41% |
| 2023 FY | 25.04 Billion CNY | 0.72% |
| 2023 Q4 | 25.04 Billion CNY | 0.99% |
| 2023 Q1 | 25.62 Billion CNY | 3.04% |
| 2023 Q3 | 24.79 Billion CNY | -3.6% |
| 2022 Q2 | 22.93 Billion CNY | -3.34% |
| 2022 Q3 | 23.56 Billion CNY | 2.76% |
| 2022 Q4 | 24.86 Billion CNY | 5.49% |
| 2022 FY | 24.86 Billion CNY | 11.14% |
| 2022 Q1 | 23.72 Billion CNY | 6.07% |
| 2021 Q4 | 22.37 Billion CNY | 3.15% |
| 2021 Q3 | 21.68 Billion CNY | 2.99% |
| 2021 FY | 22.37 Billion CNY | 8.65% |
| 2021 Q2 | 21.05 Billion CNY | -1.4% |
| 2021 Q1 | 21.35 Billion CNY | 3.73% |
| 2020 Q2 | 17.25 Billion CNY | -1.86% |
| 2020 Q1 | 17.57 Billion CNY | -2.22% |
| 2020 FY | 20.59 Billion CNY | 14.54% |
| 2020 Q3 | 19.32 Billion CNY | 11.99% |
| 2020 Q4 | 20.59 Billion CNY | 6.58% |
| 2019 FY | 17.97 Billion CNY | 3.09% |
| 2019 Q4 | 17.97 Billion CNY | 10.07% |
| 2019 Q3 | 16.33 Billion CNY | -3.24% |
| 2019 Q2 | 16.87 Billion CNY | 2.65% |
| 2019 Q1 | 16.44 Billion CNY | -5.71% |
| 2018 Q3 | 15.62 Billion CNY | 1.02% |
| 2018 Q4 | 17.43 Billion CNY | 11.62% |
| 2018 FY | 17.43 Billion CNY | 9.68% |
| 2018 Q1 | 16.15 Billion CNY | 1.63% |
| 2018 Q2 | 15.46 Billion CNY | -4.29% |
| 2017 Q2 | 15.53 Billion CNY | 37.09% |
| 2017 Q4 | 15.89 Billion CNY | 0.66% |
| 2017 Q3 | 15.79 Billion CNY | 1.64% |
| 2017 Q1 | 11.33 Billion CNY | 7.65% |
| 2017 FY | 15.89 Billion CNY | 50.99% |
| 2016 FY | 10.52 Billion CNY | 30.35% |
| 2016 Q4 | 10.52 Billion CNY | 1.14% |
| 2016 Q3 | 10.41 Billion CNY | 20.6% |
| 2016 Q2 | 8.63 Billion CNY | 4.82% |
| 2016 Q1 | 8.23 Billion CNY | 1.95% |
| 2015 Q3 | 7.87 Billion CNY | -0.77% |
| 2015 FY | 8.07 Billion CNY | 10.61% |
| 2015 Q1 | 7.68 Billion CNY | 5.18% |
| 2015 Q2 | 7.93 Billion CNY | 3.36% |
| 2015 Q4 | 8.07 Billion CNY | 2.53% |
| 2014 Q3 | 7.54 Billion CNY | 5.65% |
| 2014 Q1 | 7.13 Billion CNY | 8.62% |
| 2014 Q2 | 7.14 Billion CNY | 0.18% |
| 2014 FY | 7.3 Billion CNY | 11.22% |
| 2014 Q4 | 7.3 Billion CNY | -3.26% |
| 2013 Q2 | 6.64 Billion CNY | 11.49% |
| 2013 FY | 6.56 Billion CNY | 16.55% |
| 2013 Q4 | 6.56 Billion CNY | 0.88% |
| 2013 Q1 | 5.95 Billion CNY | 5.77% |
| 2013 Q3 | 6.5 Billion CNY | -2.03% |
| 2012 Q4 | 5.63 Billion CNY | 3.11% |
| 2012 FY | 5.63 Billion CNY | 22.4% |
| 2012 Q3 | 5.46 Billion CNY | 17.26% |
| 2012 Q1 | 4.55 Billion CNY | -1.04% |
| 2012 Q2 | 4.65 Billion CNY | 2.29% |
| 2011 FY | 4.6 Billion CNY | 25.69% |
| 2011 Q4 | 4.6 Billion CNY | 6.87% |
| 2011 Q3 | 4.3 Billion CNY | 3.15% |
| 2011 Q2 | 4.17 Billion CNY | 8.29% |
| 2011 Q1 | 3.85 Billion CNY | 5.3% |
| 2010 Q1 | 3.18 Billion CNY | 2.0% |
| 2010 Q4 | 3.66 Billion CNY | 2.31% |
| 2010 FY | 3.66 Billion CNY | 17.21% |
| 2010 Q3 | 3.57 Billion CNY | 6.08% |
| 2010 Q2 | 3.37 Billion CNY | 5.88% |
| 2009 Q4 | 3.12 Billion CNY | 4.86% |
| 2009 Q1 | 2.8 Billion CNY | -4.04% |
| 2009 Q2 | 2.87 Billion CNY | 2.35% |
| 2009 Q3 | 2.97 Billion CNY | 3.76% |
| 2009 FY | 3.12 Billion CNY | 6.86% |
| 2008 Q1 | 3 Billion CNY | 1.87% |
| 2008 Q2 | 3.02 Billion CNY | 0.93% |
| 2008 FY | 2.92 Billion CNY | -0.74% |
| 2008 Q3 | 2.98 Billion CNY | -1.54% |
| 2008 Q4 | 2.92 Billion CNY | -1.95% |
| 2007 Q2 | 2.73 Billion CNY | 2.59% |
| 2007 Q4 | 2.94 Billion CNY | -0.04% |
| 2007 FY | 2.94 Billion CNY | 19.82% |
| 2007 Q1 | 2.66 Billion CNY | 8.4% |
| 2007 Q3 | 2.94 Billion CNY | 7.79% |
| 2006 Q3 | 2.46 Billion CNY | -1.84% |
| 2006 FY | 2.45 Billion CNY | 13.62% |
| 2006 Q4 | 2.45 Billion CNY | -0.29% |
| 2006 Q2 | 2.51 Billion CNY | 9.88% |
| 2006 Q1 | 2.28 Billion CNY | 5.64% |
| 2005 Q4 | 2.16 Billion CNY | 1.38% |
| 2005 Q3 | 2.13 Billion CNY | 1.91% |
| 2005 Q2 | 2.09 Billion CNY | -1.15% |
| 2005 Q1 | 2.11 Billion CNY | -3.79% |
| 2005 FY | 2.16 Billion CNY | -1.74% |
| 2004 Q4 | 2.2 Billion CNY | 9.15% |
| 2004 Q3 | 2.01 Billion CNY | -7.85% |
| 2004 Q2 | 2.18 Billion CNY | 17.74% |
| 2004 Q1 | 1.85 Billion CNY | -12.68% |
| 2004 FY | 2.2 Billion CNY | 3.41% |
| 2003 Q2 | 1.77 Billion CNY | -4.55% |
| 2003 Q1 | 1.85 Billion CNY | -0.02% |
| 2003 FY | 2.12 Billion CNY | 14.7% |
| 2003 Q4 | 2.12 Billion CNY | 19.62% |
| 2003 Q3 | 1.77 Billion CNY | 0.47% |
| 2002 Q3 | 1.96 Billion CNY | 2.01% |
| 2002 Q1 | 1.79 Billion CNY | 6.86% |
| 2002 FY | 1.85 Billion CNY | 10.75% |
| 2002 Q2 | 1.92 Billion CNY | 7.51% |
| 2002 Q4 | 1.85 Billion CNY | -5.49% |
| 2001 Q4 | 1.67 Billion CNY | 0.0% |
| 2001 Q2 | 1.63 Billion CNY | 0.0% |
| 2001 FY | 1.67 Billion CNY | 5.53% |
| 2000 Q4 | 1.58 Billion CNY | 0.0% |
| 2000 Q2 | 1.64 Billion CNY | 0.0% |
| 2000 FY | 1.58 Billion CNY | 1.95% |
| 1999 FY | 1.55 Billion CNY | -0.2% |
| 1999 Q2 | 1.63 Billion CNY | 0.0% |
| 1999 Q4 | 1.55 Billion CNY | 0.0% |
| 1998 Q4 | 1.56 Billion CNY | 0.0% |
| 1998 Q2 | 1.5 Billion CNY | 0.0% |
| 1998 FY | 1.56 Billion CNY | 3.36% |
| 1997 Q4 | 1.51 Billion CNY | 0.0% |
| 1997 FY | 1.51 Billion CNY | 14.69% |
| 1997 Q2 | 1.38 Billion CNY | 0.0% |
| 1996 Q2 | 1.1 Billion CNY | 0.0% |
| 1996 Q4 | 1.31 Billion CNY | 0.0% |
| 1996 FY | 1.31 Billion CNY | 18.64% |
| 1995 Q4 | 1.1 Billion CNY | 0.0% |
| 1995 FY | 1.1 Billion CNY | 27.55% |
| 1995 Q2 | 1.07 Billion CNY | 0.0% |
| 1994 Q4 | 870.12 Million CNY | 0.0% |
| 1994 Q2 | 812.78 Million CNY | 0.0% |
| 1994 FY | 870.12 Million CNY | 9.14% |
| 1993 FY | 797.27 Million CNY | 34.16% |
| 1992 FY | 594.26 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -2659.867% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | -11.235% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -1845.699% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -1095.394% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -5138.221% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -766.403% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -785.74% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -1349.911% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -2867.527% |
| SSY Group Limited | 11.96 Billion HKD | -109.294% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -1703.477% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -618.264% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 90.782% |